Solid-state investigation of the tautomerism of acetohexamide

International Journal of Pharmaceutics

Volumn 146, Issue 1, 1997, Pages 93-99

  Stephenson, Gregory A ^a,c   Pfeiffer, Ralph R ^b   Byrn, Stephen R ^a  

^a PURDUE UNIVERSITY   (United States)

^b Solid State Chemical Information   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Acetohexamide; Chlorpropamide; Polymorphic firms; Solid state nuclear magnetic resonance; Tolbutamide; X ray crystal structure

Indexed keywords

ACETOHEXAMIDE; ANTIDIABETIC AGENT; CHLORPROPAMIDE; TOLBUTAMIDE;

ARTICLE; CONFORMATION; CRYSTAL STRUCTURE; DRUG STRUCTURE; HYDROGEN BOND; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TECHNIQUE; X RAY CRYSTALLOGRAPHY;

EID: 0031048147     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(96)04775-8     Document Type: Article

References (16)

1. Al-Saieq, S.S. and Riley, G.S., Polymorphism in sulphonylurea hypoglycaemic agents: III. Acetohexamide. Pharm. Acta. Helv., 57 (1982) 43-46.
2. Bar, I. and Bernstein, J., Conformational polymorphism VI. The crystal and molecular structures of form II, form III, and form V of 4-Amino-N-2-pyridinylbenzenesulfonamide (sulfapyridine). J. Pharm. Sci., 74 (1984) 255-263.
3. Bellamy, L.J., In The Infrared Spectra of Complex Molecules, 2nd edn., Vol. 2, Chapman and Hall, New York, 1980, pp. 155-157.
4. Burger, A., Acetohexamide: thermodynamics and biopharmaceutical aspects. Sci. Pharm., 46 (1978) 207-222.
5. Byrn, S.R., Solid-State Chemistry of Drugs, Academic Press, New York, 1982.
6. Cambridge Crystallographic Data Centre, The Cambridge Structural Database, University Chemical Laboratory, Cambridge, UK, 1996.
7. Donaldson, J.D., Leary, J.R., Ross, S.D. and Thomas, M.J.K., The structure of the orthorhombic form of tolbutamide. Acta Cryst. B, 37 (1981) 2245-2248.
8. Etter, M.C., Reutzel, S.M. and Vojta, G.M., Analysis of isotropic chemical shift data from high-resolution solid-state NMR studies of hydrogen-bonded organic compounds. J. Mol. Struct., 237 (1990) 165-185.
9. Graf, E., Beyer, C. and Abdallah, O., On the polymorphism of acetohexamide. Pharm. Ind., 46 (1984) 955-959.
10. Girgis-Takla, P. and Chroneos, I., The polymorphism of acetohexamide. J. Pharm. Pharmacol., 29 (1977) 640-642.
11. Girgis-Takla, P. and Dakas, C.J., An infrared study of tautomerism in acetohexamide polymorphs. J. Pharm. Pharmacol., 41 (1989) 227-230.
12. Johnson, C.K., ORTEPII: Report ORNL-5138, Oak Ridge National Laboratory, Oak Ridge, TN, 1976.
13. Koo, C.H., Cho, S.I. and Yeon, Y.H., The crystal and molecular structure of chlorpropamide. Arch. Pharmacal. Res., 3 (1980) 37-49.
14. Sheldrick, G.M., SHELX 86: Program for the solution of crystal structures. Institut für Anorganische Chemie der Universität Göttingen, Göttingen, Germany, 1986.
15. Smith, D.K., POW12. Penn State University, University Park, PA, 1989.
16. Yokoyama, T., Umeda, T., Kuroda, K., Sato, K. and Takagishi, Y., Studies on drug nonequivalence. VII. Bioavailability of acetohexamide polymorphs, Chem. Pharm. Bull., 27 (1979) 1476-1478.